 | • レポートコード：MRC2Q12-02297 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：化学&材料 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、ラロトレクチニブAPIの世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にラロトレクチニブAPIのグローバル市場のxxx％を占める「0.98」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「医療製薬」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 ラロトレクチニブAPIの中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのラロトレクチニブAPI市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 ラロトレクチニブAPIのグローバル主要プレイヤーには、Hunan Huateng Pharmaceutical、Changzhou Pharmaceutical Factory、Shandong Haohong Biotechnology、Teva API、Mylan Incなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ラロトレクチニブAPI市場は、種類と用途によって区分されます。世界のラロトレクチニブAPI市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 0.98、0.99、0.995、その他 【用途別セグメント】 医療製薬、科学研究 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ラロトレクチニブAPI製品概要 - 種類別市場（0.98、0.99、0.995、その他） - 用途別市場（医療製薬、科学研究） - 調査の目的 ・エグゼクティブサマリー - 世界のラロトレクチニブAPI販売量予測2017-2028 - 世界のラロトレクチニブAPI売上予測2017-2028 - ラロトレクチニブAPIの地域別販売量 - ラロトレクチニブAPIの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ラロトレクチニブAPI販売量 - 主要メーカー別ラロトレクチニブAPI売上 - 主要メーカー別ラロトレクチニブAPI価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（0.98、0.99、0.995、その他） - ラロトレクチニブAPIの種類別販売量 - ラロトレクチニブAPIの種類別売上 - ラロトレクチニブAPIの種類別価格 ・用途別市場規模（医療製薬、科学研究） - ラロトレクチニブAPIの用途別販売量 - ラロトレクチニブAPIの用途別売上 - ラロトレクチニブAPIの用途別価格 ・北米市場 - 北米のラロトレクチニブAPI市場規模（種類別、用途別） - 主要国別のラロトレクチニブAPI市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのラロトレクチニブAPI市場規模（種類別、用途別） - 主要国別のラロトレクチニブAPI市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のラロトレクチニブAPI市場規模（種類別、用途別） - 主要国別のラロトレクチニブAPI市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のラロトレクチニブAPI市場規模（種類別、用途別） - 主要国別のラロトレクチニブAPI市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのラロトレクチニブAPI市場規模（種類別、用途別） - 主要国別のラロトレクチニブAPI市場規模（トルコ、サウジアラビア） ・企業情報 Hunan Huateng Pharmaceutical、Changzhou Pharmaceutical Factory、Shandong Haohong Biotechnology、Teva API、Mylan Inc ・産業チェーン及び販売チャネル分析 - ラロトレクチニブAPIの産業チェーン分析 - ラロトレクチニブAPIの原材料 - ラロトレクチニブAPIの生産プロセス - ラロトレクチニブAPIの販売及びマーケティング - ラロトレクチニブAPIの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ラロトレクチニブAPIの産業動向 - ラロトレクチニブAPIのマーケットドライバー - ラロトレクチニブAPIの課題 - ラロトレクチニブAPIの阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Larotrectinib API estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Larotrectinib API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Larotrectinib API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Larotrectinib API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Larotrectinib API include Hunan Huateng Pharmaceutical, Changzhou Pharmaceutical Factory, Shandong Haohong Biotechnology, Teva API and Mylan Inc, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Larotrectinib API production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Larotrectinib API by region (region level and country level), by company, by Purity and by Application. from 2017 to 2022 and forecast to 2028.
Report Scope
This latest report researches the industry structure, capacity, production, sales (consumption), revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Larotrectinib API manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Larotrectinib API market. Further, it explains the major drivers and regional dynamics of the global Larotrectinib API market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Hunan Huateng Pharmaceutical
Changzhou Pharmaceutical Factory
Shandong Haohong Biotechnology
Teva API
Mylan Inc
Market Segments
This report has explored the key segments: by Purity and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on production, price, and value for the period 2017-2028.
Larotrectinib API Segment by Purity
0.98
0.99
0.995
Others
Larotrectinib API Segment by Application
Medical Pharmaceutical
Scientific Research
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. This report analyzes the Larotrectinib API production by region/country, and the sales (consumption) by region/country. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Larotrectinib API market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Larotrectinib API, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Larotrectinib API, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Larotrectinib API, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Larotrectinib API sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Larotrectinib API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Larotrectinib API sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Hunan Huateng Pharmaceutical, Changzhou Pharmaceutical Factory, Shandong Haohong Biotechnology, Teva API and Mylan Inc, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Larotrectinib API capacity, production/output of global and key producers (regions/countries). It provides a quantitative analysis of the capacity, production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Larotrectinib API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Larotrectinib API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by purity, by application and by country, sales and revenue for each segment.
Chapter 8: Europe by purity, by application and by country, sales and revenue for each segment.
Chapter 9: Asia Pacific by purity, by application and by country, sales and revenue for each segment.
Chapter 10: Latin America by purity, by application and by country, sales and revenue for each segment.
Chapter 11: Middle East and Africa by purity, by application and by country, sales and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Larotrectinib API sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
1 Study Coverage
1.1 Larotrectinib API Product Introduction
1.2 Market by Purity
1.2.1 Global Larotrectinib API Market Size by Purity, 2017 VS 2021 VS 2028
1.2.2 0.98
1.2.3 0.99
1.2.4 0.995
1.2.5 Others
1.3 Market by Application
1.3.1 Global Larotrectinib API Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Medical Pharmaceutical
1.3.3 Scientific Research
1.4 Study Objectives
1.5 Years Considered
2 Global Larotrectinib API Production
2.1 Global Larotrectinib API Production Capacity (2017-2028)
2.2 Global Larotrectinib API Production by Region: 2017 VS 2021 VS 2028
2.3 Global Larotrectinib API Production by Region
2.3.1 Global Larotrectinib API Historic Production by Region (2017-2022)
2.3.2 Global Larotrectinib API Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Larotrectinib API Sales in Volume & Value Estimates and Forecasts
3.1 Global Larotrectinib API Sales Estimates and Forecasts 2017-2028
3.2 Global Larotrectinib API Revenue Estimates and Forecasts 2017-2028
3.3 Global Larotrectinib API Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Larotrectinib API Sales by Region
3.4.1 Global Larotrectinib API Sales by Region (2017-2022)
3.4.2 Global Sales Larotrectinib API by Region (2023-2028)
3.5 Global Larotrectinib API Revenue by Region
3.5.1 Global Larotrectinib API Revenue by Region (2017-2022)
3.5.2 Global Larotrectinib API Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Larotrectinib API Production Capacity by Manufacturers
4.2 Global Larotrectinib API Sales by Manufacturers
4.2.1 Global Larotrectinib API Sales by Manufacturers (2017-2022)
4.2.2 Global Larotrectinib API Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Larotrectinib API in 2021
4.3 Global Larotrectinib API Revenue by Manufacturers
4.3.1 Global Larotrectinib API Revenue by Manufacturers (2017-2022)
4.3.2 Global Larotrectinib API Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Larotrectinib API Revenue in 2021
4.4 Global Larotrectinib API Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Larotrectinib API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Larotrectinib API Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Purity
5.1 Global Larotrectinib API Sales by Purity
5.1.1 Global Larotrectinib API Historical Sales by Purity (2017-2022)
5.1.2 Global Larotrectinib API Forecasted Sales by Purity (2023-2028)
5.1.3 Global Larotrectinib API Sales Market Share by Purity (2017-2028)
5.2 Global Larotrectinib API Revenue by Purity
5.2.1 Global Larotrectinib API Historical Revenue by Purity (2017-2022)
5.2.2 Global Larotrectinib API Forecasted Revenue by Purity (2023-2028)
5.2.3 Global Larotrectinib API Revenue Market Share by Purity (2017-2028)
5.3 Global Larotrectinib API Price by Purity
5.3.1 Global Larotrectinib API Price by Purity (2017-2022)
5.3.2 Global Larotrectinib API Price Forecast by Purity (2023-2028)
6 Market Size by Application
6.1 Global Larotrectinib API Sales by Application
6.1.1 Global Larotrectinib API Historical Sales by Application (2017-2022)
6.1.2 Global Larotrectinib API Forecasted Sales by Application (2023-2028)
6.1.3 Global Larotrectinib API Sales Market Share by Application (2017-2028)
6.2 Global Larotrectinib API Revenue by Application
6.2.1 Global Larotrectinib API Historical Revenue by Application (2017-2022)
6.2.2 Global Larotrectinib API Forecasted Revenue by Application (2023-2028)
6.2.3 Global Larotrectinib API Revenue Market Share by Application (2017-2028)
6.3 Global Larotrectinib API Price by Application
6.3.1 Global Larotrectinib API Price by Application (2017-2022)
6.3.2 Global Larotrectinib API Price Forecast by Application (2023-2028)
7 North America
7.1 North America Larotrectinib API Market Size by Purity
7.1.1 North America Larotrectinib API Sales by Purity (2017-2028)
7.1.2 North America Larotrectinib API Revenue by Purity (2017-2028)
7.2 North America Larotrectinib API Market Size by Application
7.2.1 North America Larotrectinib API Sales by Application (2017-2028)
7.2.2 North America Larotrectinib API Revenue by Application (2017-2028)
7.3 North America Larotrectinib API Sales by Country
7.3.1 North America Larotrectinib API Sales by Country (2017-2028)
7.3.2 North America Larotrectinib API Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Larotrectinib API Market Size by Purity
8.1.1 Europe Larotrectinib API Sales by Purity (2017-2028)
8.1.2 Europe Larotrectinib API Revenue by Purity (2017-2028)
8.2 Europe Larotrectinib API Market Size by Application
8.2.1 Europe Larotrectinib API Sales by Application (2017-2028)
8.2.2 Europe Larotrectinib API Revenue by Application (2017-2028)
8.3 Europe Larotrectinib API Sales by Country
8.3.1 Europe Larotrectinib API Sales by Country (2017-2028)
8.3.2 Europe Larotrectinib API Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Larotrectinib API Market Size by Purity
9.1.1 Asia Pacific Larotrectinib API Sales by Purity (2017-2028)
9.1.2 Asia Pacific Larotrectinib API Revenue by Purity (2017-2028)
9.2 Asia Pacific Larotrectinib API Market Size by Application
9.2.1 Asia Pacific Larotrectinib API Sales by Application (2017-2028)
9.2.2 Asia Pacific Larotrectinib API Revenue by Application (2017-2028)
9.3 Asia Pacific Larotrectinib API Sales by Region
9.3.1 Asia Pacific Larotrectinib API Sales by Region (2017-2028)
9.3.2 Asia Pacific Larotrectinib API Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Larotrectinib API Market Size by Purity
10.1.1 Latin America Larotrectinib API Sales by Purity (2017-2028)
10.1.2 Latin America Larotrectinib API Revenue by Purity (2017-2028)
10.2 Latin America Larotrectinib API Market Size by Application
10.2.1 Latin America Larotrectinib API Sales by Application (2017-2028)
10.2.2 Latin America Larotrectinib API Revenue by Application (2017-2028)
10.3 Latin America Larotrectinib API Sales by Country
10.3.1 Latin America Larotrectinib API Sales by Country (2017-2028)
10.3.2 Latin America Larotrectinib API Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Larotrectinib API Market Size by Purity
11.1.1 Middle East and Africa Larotrectinib API Sales by Purity (2017-2028)
11.1.2 Middle East and Africa Larotrectinib API Revenue by Purity (2017-2028)
11.2 Middle East and Africa Larotrectinib API Market Size by Application
11.2.1 Middle East and Africa Larotrectinib API Sales by Application (2017-2028)
11.2.2 Middle East and Africa Larotrectinib API Revenue by Application (2017-2028)
11.3 Middle East and Africa Larotrectinib API Sales by Country
11.3.1 Middle East and Africa Larotrectinib API Sales by Country (2017-2028)
11.3.2 Middle East and Africa Larotrectinib API Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Hunan Huateng Pharmaceutical
12.1.1 Hunan Huateng Pharmaceutical Corporation Information
12.1.2 Hunan Huateng Pharmaceutical Overview
12.1.3 Hunan Huateng Pharmaceutical Larotrectinib API Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Hunan Huateng Pharmaceutical Larotrectinib API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Hunan Huateng Pharmaceutical Recent Developments
12.2 Changzhou Pharmaceutical Factory
12.2.1 Changzhou Pharmaceutical Factory Corporation Information
12.2.2 Changzhou Pharmaceutical Factory Overview
12.2.3 Changzhou Pharmaceutical Factory Larotrectinib API Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Changzhou Pharmaceutical Factory Larotrectinib API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Changzhou Pharmaceutical Factory Recent Developments
12.3 Shandong Haohong Biotechnology
12.3.1 Shandong Haohong Biotechnology Corporation Information
12.3.2 Shandong Haohong Biotechnology Overview
12.3.3 Shandong Haohong Biotechnology Larotrectinib API Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Shandong Haohong Biotechnology Larotrectinib API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Shandong Haohong Biotechnology Recent Developments
12.4 Teva API
12.4.1 Teva API Corporation Information
12.4.2 Teva API Overview
12.4.3 Teva API Larotrectinib API Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Teva API Larotrectinib API Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Teva API Recent Developments
12.5 Mylan Inc
12.5.1 Mylan Inc Corporation Information
12.5.2 Mylan Inc Overview
12.5.3 Mylan Inc Larotrectinib API Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Mylan Inc Larotrectinib API Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Mylan Inc Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Larotrectinib API Industry Chain Analysis
13.2 Larotrectinib API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Larotrectinib API Production Mode & Process
13.4 Larotrectinib API Sales and Marketing
13.4.1 Larotrectinib API Sales Channels
13.4.2 Larotrectinib API Distributors
13.5 Larotrectinib API Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Larotrectinib API Industry Trends
14.2 Larotrectinib API Market Drivers
14.3 Larotrectinib API Market Challenges
14.4 Larotrectinib API Market Restraints
15 Key Finding in The Global Larotrectinib API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Larotrectinib API Market Size Growth Rate by Purity, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 0.98
Table 3. Major Manufacturers of 0.99
Table 4. Major Manufacturers of 0.995
Table 5. Major Manufacturers of Others
Table 6. Global Larotrectinib API Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 7. Global Larotrectinib API Production by Region: 2017 VS 2021 VS 2028 (Tons)
Table 8. Global Larotrectinib API Production by Region (2017-2022) & (Tons)
Table 9. Global Larotrectinib API Production Market Share by Region (2017-2022)
Table 10. Global Larotrectinib API Production by Region (2023-2028) & (Tons)
Table 11. Global Larotrectinib API Production Market Share by Region (2023-2028)
Table 12. Global Larotrectinib API Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 13. Global Larotrectinib API Sales by Region (2017-2022) & (Tons)
Table 14. Global Larotrectinib API Sales Market Share by Region (2017-2022)
Table 15. Global Larotrectinib API Sales by Region (2023-2028) & (Tons)
Table 16. Global Larotrectinib API Sales Market Share by Region (2023-2028)
Table 17. Global Larotrectinib API Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Larotrectinib API Revenue Market Share by Region (2017-2022)
Table 19. Global Larotrectinib API Revenue by Region (2023-2028) & (US$ Million)
Table 20. Global Larotrectinib API Revenue Market Share by Region (2023-2028)
Table 21. Global Larotrectinib API Production Capacity by Manufacturers (2017-2022) & (Tons)
Table 22. Global Larotrectinib API Capacity Market Share by Manufacturers (2017-2022)
Table 23. Global Larotrectinib API Sales by Manufacturers (2017-2022) & (Tons)
Table 24. Global Larotrectinib API Sales Market Share by Manufacturers (2017-2022)
Table 25. Global Larotrectinib API Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 26. Global Larotrectinib API Revenue Share by Manufacturers (2017-2022)
Table 27. Larotrectinib API Price by Manufacturers 2017-2022 (US$/Kg)
Table 28. Global Larotrectinib API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 29. Global Larotrectinib API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Larotrectinib API as of 2021)
Table 30. Larotrectinib API Manufacturing Base Distribution and Headquarters
Table 31. Manufacturers Larotrectinib API Product Offered
Table 32. Date of Manufacturers Enter into Larotrectinib API Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Larotrectinib API Sales by Purity (2017-2022) & (Tons)
Table 35. Global Larotrectinib API Sales by Purity (2023-2028) & (Tons)
Table 36. Global Larotrectinib API Sales Share by Purity (2017-2022)
Table 37. Global Larotrectinib API Sales Share by Purity (2023-2028)
Table 38. Global Larotrectinib API Revenue by Purity (2017-2022) & (US$ Million)
Table 39. Global Larotrectinib API Revenue by Purity (2023-2028) & (US$ Million)
Table 40. Global Larotrectinib API Revenue Share by Purity (2017-2022)
Table 41. Global Larotrectinib API Revenue Share by Purity (2023-2028)
Table 42. Larotrectinib API Price by Purity (2017-2022) & (US$/Kg)
Table 43. Global Larotrectinib API Price Forecast by Purity (2023-2028) & (US$/Kg)
Table 44. Global Larotrectinib API Sales by Application (2017-2022) & (Tons)
Table 45. Global Larotrectinib API Sales by Application (2023-2028) & (Tons)
Table 46. Global Larotrectinib API Sales Share by Application (2017-2022)
Table 47. Global Larotrectinib API Sales Share by Application (2023-2028)
Table 48. Global Larotrectinib API Revenue by Application (2017-2022) & (US$ Million)
Table 49. Global Larotrectinib API Revenue by Application (2023-2028) & (US$ Million)
Table 50. Global Larotrectinib API Revenue Share by Application (2017-2022)
Table 51. Global Larotrectinib API Revenue Share by Application (2023-2028)
Table 52. Larotrectinib API Price by Application (2017-2022) & (US$/Kg)
Table 53. Global Larotrectinib API Price Forecast by Application (2023-2028) & (US$/Kg)
Table 54. North America Larotrectinib API Sales by Purity (2017-2022) & (Tons)
Table 55. North America Larotrectinib API Sales by Purity (2023-2028) & (Tons)
Table 56. North America Larotrectinib API Revenue by Purity (2017-2022) & (US$ Million)
Table 57. North America Larotrectinib API Revenue by Purity (2023-2028) & (US$ Million)
Table 58. North America Larotrectinib API Sales by Application (2017-2022) & (Tons)
Table 59. North America Larotrectinib API Sales by Application (2023-2028) & (Tons)
Table 60. North America Larotrectinib API Revenue by Application (2017-2022) & (US$ Million)
Table 61. North America Larotrectinib API Revenue by Application (2023-2028) & (US$ Million)
Table 62. North America Larotrectinib API Sales by Country (2017-2022) & (Tons)
Table 63. North America Larotrectinib API Sales by Country (2023-2028) & (Tons)
Table 64. North America Larotrectinib API Revenue by Country (2017-2022) & (US$ Million)
Table 65. North America Larotrectinib API Revenue by Country (2023-2028) & (US$ Million)
Table 66. Europe Larotrectinib API Sales by Purity (2017-2022) & (Tons)
Table 67. Europe Larotrectinib API Sales by Purity (2023-2028) & (Tons)
Table 68. Europe Larotrectinib API Revenue by Purity (2017-2022) & (US$ Million)
Table 69. Europe Larotrectinib API Revenue by Purity (2023-2028) & (US$ Million)
Table 70. Europe Larotrectinib API Sales by Application (2017-2022) & (Tons)
Table 71. Europe Larotrectinib API Sales by Application (2023-2028) & (Tons)
Table 72. Europe Larotrectinib API Revenue by Application (2017-2022) & (US$ Million)
Table 73. Europe Larotrectinib API Revenue by Application (2023-2028) & (US$ Million)
Table 74. Europe Larotrectinib API Sales by Country (2017-2022) & (Tons)
Table 75. Europe Larotrectinib API Sales by Country (2023-2028) & (Tons)
Table 76. Europe Larotrectinib API Revenue by Country (2017-2022) & (US$ Million)
Table 77. Europe Larotrectinib API Revenue by Country (2023-2028) & (US$ Million)
Table 78. Asia Pacific Larotrectinib API Sales by Purity (2017-2022) & (Tons)
Table 79. Asia Pacific Larotrectinib API Sales by Purity (2023-2028) & (Tons)
Table 80. Asia Pacific Larotrectinib API Revenue by Purity (2017-2022) & (US$ Million)
Table 81. Asia Pacific Larotrectinib API Revenue by Purity (2023-2028) & (US$ Million)
Table 82. Asia Pacific Larotrectinib API Sales by Application (2017-2022) & (Tons)
Table 83. Asia Pacific Larotrectinib API Sales by Application (2023-2028) & (Tons)
Table 84. Asia Pacific Larotrectinib API Revenue by Application (2017-2022) & (US$ Million)
Table 85. Asia Pacific Larotrectinib API Revenue by Application (2023-2028) & (US$ Million)
Table 86. Asia Pacific Larotrectinib API Sales by Region (2017-2022) & (Tons)
Table 87. Asia Pacific Larotrectinib API Sales by Region (2023-2028) & (Tons)
Table 88. Asia Pacific Larotrectinib API Revenue by Region (2017-2022) & (US$ Million)
Table 89. Asia Pacific Larotrectinib API Revenue by Region (2023-2028) & (US$ Million)
Table 90. Latin America Larotrectinib API Sales by Purity (2017-2022) & (Tons)
Table 91. Latin America Larotrectinib API Sales by Purity (2023-2028) & (Tons)
Table 92. Latin America Larotrectinib API Revenue by Purity (2017-2022) & (US$ Million)
Table 93. Latin America Larotrectinib API Revenue by Purity (2023-2028) & (US$ Million)
Table 94. Latin America Larotrectinib API Sales by Application (2017-2022) & (Tons)
Table 95. Latin America Larotrectinib API Sales by Application (2023-2028) & (Tons)
Table 96. Latin America Larotrectinib API Revenue by Application (2017-2022) & (US$ Million)
Table 97. Latin America Larotrectinib API Revenue by Application (2023-2028) & (US$ Million)
Table 98. Latin America Larotrectinib API Sales by Country (2017-2022) & (Tons)
Table 99. Latin America Larotrectinib API Sales by Country (2023-2028) & (Tons)
Table 100. Latin America Larotrectinib API Revenue by Country (2017-2022) & (US$ Million)
Table 101. Latin America Larotrectinib API Revenue by Country (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Larotrectinib API Sales by Purity (2017-2022) & (Tons)
Table 103. Middle East and Africa Larotrectinib API Sales by Purity (2023-2028) & (Tons)
Table 104. Middle East and Africa Larotrectinib API Revenue by Purity (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Larotrectinib API Revenue by Purity (2023-2028) & (US$ Million)
Table 106. Middle East and Africa Larotrectinib API Sales by Application (2017-2022) & (Tons)
Table 107. Middle East and Africa Larotrectinib API Sales by Application (2023-2028) & (Tons)
Table 108. Middle East and Africa Larotrectinib API Revenue by Application (2017-2022) & (US$ Million)
Table 109. Middle East and Africa Larotrectinib API Revenue by Application (2023-2028) & (US$ Million)
Table 110. Middle East and Africa Larotrectinib API Sales by Country (2017-2022) & (Tons)
Table 111. Middle East and Africa Larotrectinib API Sales by Country (2023-2028) & (Tons)
Table 112. Middle East and Africa Larotrectinib API Revenue by Country (2017-2022) & (US$ Million)
Table 113. Middle East and Africa Larotrectinib API Revenue by Country (2023-2028) & (US$ Million)
Table 114. Hunan Huateng Pharmaceutical Corporation Information
Table 115. Hunan Huateng Pharmaceutical Description and Major Businesses
Table 116. Hunan Huateng Pharmaceutical Larotrectinib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 117. Hunan Huateng Pharmaceutical Larotrectinib API Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Hunan Huateng Pharmaceutical Recent Development
Table 119. Changzhou Pharmaceutical Factory Corporation Information
Table 120. Changzhou Pharmaceutical Factory Description and Major Businesses
Table 121. Changzhou Pharmaceutical Factory Larotrectinib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 122. Changzhou Pharmaceutical Factory Larotrectinib API Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Changzhou Pharmaceutical Factory Recent Development
Table 124. Shandong Haohong Biotechnology Corporation Information
Table 125. Shandong Haohong Biotechnology Description and Major Businesses
Table 126. Shandong Haohong Biotechnology Larotrectinib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 127. Shandong Haohong Biotechnology Larotrectinib API Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Shandong Haohong Biotechnology Recent Development
Table 129. Teva API Corporation Information
Table 130. Teva API Description and Major Businesses
Table 131. Teva API Larotrectinib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 132. Teva API Larotrectinib API Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Teva API Recent Development
Table 134. Mylan Inc Corporation Information
Table 135. Mylan Inc Description and Major Businesses
Table 136. Mylan Inc Larotrectinib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 137. Mylan Inc Larotrectinib API Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Mylan Inc Recent Development
Table 139. Key Raw Materials Lists
Table 140. Raw Materials Key Suppliers Lists
Table 141. Larotrectinib API Distributors List
Table 142. Larotrectinib API Customers List
Table 143. Larotrectinib API Market Trends
Table 144. Larotrectinib API Market Drivers
Table 145. Larotrectinib API Market Challenges
Table 146. Larotrectinib API Market Restraints
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Larotrectinib API Product Picture
Figure 2. Global Larotrectinib API Market Share by Purity in 2021 & 2028
Figure 3. 0.98 Product Picture
Figure 4. 0.99 Product Picture
Figure 5. 0.995 Product Picture
Figure 6. Others Product Picture
Figure 7. Global Larotrectinib API Market Share by Application in 2021 & 2028
Figure 8. Medical Pharmaceutical
Figure 9. Scientific Research
Figure 10. Larotrectinib API Report Years Considered
Figure 11. Global Larotrectinib API Capacity, Production and Utilization (2017-2028) & (Tons)
Figure 12. Global Larotrectinib API Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Larotrectinib API Production Market Share by Region (2017-2022)
Figure 14. Global Larotrectinib API Production Market Share by Region (2023-2028)
Figure 15. Larotrectinib API Production Growth Rate in North America (2017-2028) & (Tons)
Figure 16. Larotrectinib API Production Growth Rate in Europe (2017-2028) & (Tons)
Figure 17. Larotrectinib API Production Growth Rate in China (2017-2028) & (Tons)
Figure 18. Larotrectinib API Production Growth Rate in Japan (2017-2028) & (Tons)
Figure 19. Global Larotrectinib API Sales 2017-2028 (Tons)
Figure 20. Global Larotrectinib API Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 21. Global Larotrectinib API Revenue 2017-2028 (US$ Million)
Figure 22. Global Larotrectinib API Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 23. Global Larotrectinib API Sales Market Share by Region (2017-2022)
Figure 24. Global Larotrectinib API Sales Market Share by Region (2023-2028)
Figure 25. North America Larotrectinib API Sales YoY (2017-2028) & (Tons)
Figure 26. North America Larotrectinib API Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Europe Larotrectinib API Sales YoY (2017-2028) & (Tons)
Figure 28. Europe Larotrectinib API Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Larotrectinib API Sales YoY (2017-2028) & (Tons)
Figure 30. Asia-Pacific Larotrectinib API Revenue YoY (2017-2028) & (US$ Million)
Figure 31. Latin America Larotrectinib API Sales YoY (2017-2028) & (Tons)
Figure 32. Latin America Larotrectinib API Revenue YoY (2017-2028) & (US$ Million)
Figure 33. Middle East & Africa Larotrectinib API Sales YoY (2017-2028) & (Tons)
Figure 34. Middle East & Africa Larotrectinib API Revenue YoY (2017-2028) & (US$ Million)
Figure 35. The Larotrectinib API Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 36. The Top 5 and 10 Largest Manufacturers of Larotrectinib API in the World: Market Share by Larotrectinib API Revenue in 2021
Figure 37. Larotrectinib API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 38. Global Larotrectinib API Sales Market Share by Purity (2017-2028)
Figure 39. Global Larotrectinib API Revenue Market Share by Purity (2017-2028)
Figure 40. Global Larotrectinib API Sales Market Share by Application (2017-2028)
Figure 41. Global Larotrectinib API Revenue Market Share by Application (2017-2028)
Figure 42. North America Larotrectinib API Sales Market Share by Purity (2017-2028)
Figure 43. North America Larotrectinib API Revenue Market Share by Purity (2017-2028)
Figure 44. North America Larotrectinib API Sales Market Share by Application (2017-2028)
Figure 45. North America Larotrectinib API Revenue Market Share by Application (2017-2028)
Figure 46. North America Larotrectinib API Sales Share by Country (2017-2028)
Figure 47. North America Larotrectinib API Revenue Share by Country (2017-2028)
Figure 48. United States Larotrectinib API Revenue (2017-2028) & (US$ Million)
Figure 49. Canada Larotrectinib API Revenue (2017-2028) & (US$ Million)
Figure 50. Europe Larotrectinib API Sales Market Share by Purity (2017-2028)
Figure 51. Europe Larotrectinib API Revenue Market Share by Purity (2017-2028)
Figure 52. Europe Larotrectinib API Sales Market Share by Application (2017-2028)
Figure 53. Europe Larotrectinib API Revenue Market Share by Application (2017-2028)
Figure 54. Europe Larotrectinib API Sales Share by Country (2017-2028)
Figure 55. Europe Larotrectinib API Revenue Share by Country (2017-2028)
Figure 56. Germany Larotrectinib API Revenue (2017-2028) & (US$ Million)
Figure 57. France Larotrectinib API Revenue (2017-2028) & (US$ Million)
Figure 58. U.K. Larotrectinib API Revenue (2017-2028) & (US$ Million)
Figure 59. Italy Larotrectinib API Revenue (2017-2028) & (US$ Million)
Figure 60. Russia Larotrectinib API Revenue (2017-2028) & (US$ Million)
Figure 61. Asia Pacific Larotrectinib API Sales Market Share by Purity (2017-2028)
Figure 62. Asia Pacific Larotrectinib API Revenue Market Share by Purity (2017-2028)
Figure 63. Asia Pacific Larotrectinib API Sales Market Share by Application (2017-2028)
Figure 64. Asia Pacific Larotrectinib API Revenue Market Share by Application (2017-2028)
Figure 65. Asia Pacific Larotrectinib API Sales Share by Region (2017-2028)
Figure 66. Asia Pacific Larotrectinib API Revenue Share by Region (2017-2028)
Figure 67. China Larotrectinib API Revenue (2017-2028) & (US$ Million)
Figure 68. Japan Larotrectinib API Revenue (2017-2028) & (US$ Million)
Figure 69. South Korea Larotrectinib API Revenue (2017-2028) & (US$ Million)
Figure 70. India Larotrectinib API Revenue (2017-2028) & (US$ Million)
Figure 71. Australia Larotrectinib API Revenue (2017-2028) & (US$ Million)
Figure 72. China Taiwan Larotrectinib API Revenue (2017-2028) & (US$ Million)
Figure 73. Indonesia Larotrectinib API Revenue (2017-2028) & (US$ Million)
Figure 74. Thailand Larotrectinib API Revenue (2017-2028) & (US$ Million)
Figure 75. Malaysia Larotrectinib API Revenue (2017-2028) & (US$ Million)
Figure 76. Latin America Larotrectinib API Sales Market Share by Purity (2017-2028)
Figure 77. Latin America Larotrectinib API Revenue Market Share by Purity (2017-2028)
Figure 78. Latin America Larotrectinib API Sales Market Share by Application (2017-2028)
Figure 79. Latin America Larotrectinib API Revenue Market Share by Application (2017-2028)
Figure 80. Latin America Larotrectinib API Sales Share by Country (2017-2028)
Figure 81. Latin America Larotrectinib API Revenue Share by Country (2017-2028)
Figure 82. Mexico Larotrectinib API Revenue (2017-2028) & (US$ Million)
Figure 83. Brazil Larotrectinib API Revenue (2017-2028) & (US$ Million)
Figure 84. Argentina Larotrectinib API Revenue (2017-2028) & (US$ Million)
Figure 85. Colombia Larotrectinib API Revenue (2017-2028) & (US$ Million)
Figure 86. Middle East and Africa Larotrectinib API Sales Market Share by Purity (2017-2028)
Figure 87. Middle East and Africa Larotrectinib API Revenue Market Share by Purity (2017-2028)
Figure 88. Middle East and Africa Larotrectinib API Sales Market Share by Application (2017-2028)
Figure 89. Middle East and Africa Larotrectinib API Revenue Market Share by Application (2017-2028)
Figure 90. Middle East and Africa Larotrectinib API Sales Share by Country (2017-2028)
Figure 91. Middle East and Africa Larotrectinib API Revenue Share by Country (2017-2028)
Figure 92. Turkey Larotrectinib API Revenue (2017-2028) & (US$ Million)
Figure 93. Saudi Arabia Larotrectinib API Revenue (2017-2028) & (US$ Million)
Figure 94. UAE Larotrectinib API Revenue (2017-2028) & (US$ Million)
Figure 95. Larotrectinib API Value Chain
Figure 96. Larotrectinib API Production Process
Figure 97. Channels of Distribution
Figure 98. Distributors Profiles
Figure 99. Bottom-up and Top-down Approaches for This Report
Figure 100. Data Triangulation
Figure 101. Key Executives Interviewed